The instinct is reasonable. You have a capable regional manager. Korea is one market. Trade agencies will arrange introductions for free. Why pay an adviser to do what a competent employee can do with two trips and a spreadsheet?
Because the things that go wrong in Korea are not the things a visiting manager can see.
What in-house does well
Let us be honest about this first. Nobody outside your company understands your brand better than you do. Product decisions, price architecture, which collections travel and which do not, what you are unwilling to compromise. Those judgements should never be outsourced, and a good adviser will not try.
The problem is that market entry is not mostly brand judgement. It is mostly verification, sequencing and drafting, performed against a legal and commercial system you have not operated in.
Four costs that do not appear in the in-house plan
1. The trademark you cannot buy back at a sensible price
Korea is a first-to-file jurisdiction. Registration, not use, generally determines who owns a mark. A brand that spends nine months evaluating the market before filing may find that someone who noticed its interest has filed first. Recovering the mark then becomes a commercial negotiation with a party who knows exactly what it is worth to you.
This is the single most preventable loss in Korean market entry, and it is preventable for a fraction of what recovery costs.
2. Time, priced properly
An in-house entry typically runs twelve to eighteen months: research, introductions, shortlisting, negotiation, certification, launch. Much of that time is spent discovering things that were already knowable, such as which certifications apply, which distributors already hold competing lines, and which channel a category actually sells through.
Six months of avoidable delay is not a soft cost. It is a season of sell-through, a year of competitor entrenchment, and the salary of everyone who spent that time learning.
3. The partner you cannot unpick
Exclusive distribution agreements are easy to sign and hard to exit. A manager on their second visit is not positioned to assess a counterparty's ownership structure, litigation history, subcontractor practices or existing territory commitments, and will usually sign the distributor's draft, which is written to make termination expensive.
The cost of the wrong partner is rarely the lost revenue. It is the three years during which you cannot enter properly because someone else holds the rights.
4. Certification discovered late
KC safety certification, material and food-contact standards, labelling rules, e-commerce disclosure requirements. Each is knowable in advance. Each, discovered after production, means rework, re-testing, or a container sitting at Busan.
What you are actually buying from an adviser
Not opinions. Three specific things.
- Verification. Filings searched, counterparties checked, regulatory requirements confirmed against your actual SKUs rather than your category.
- Sequencing. Knowing what must happen before what. File before you negotiate, certify before you commit to dates, structure before you sign exclusivity.
- Drafting that works in Korea. A distribution agreement drafted for a European supply chain and applied unedited to a Korean counterparty is a dispute with a delay built in.
The honest comparison
The in-house route is not more expensive because advisers are cheap. It is more expensive because the errors are asymmetric. A brand doing this itself will get most decisions right and one or two badly wrong, and in Korea the wrong ones are the expensive ones. Trademark loss, a locked exclusive agreement, and a failed certification are each capable of costing more than an entire advisory engagement.
The value is not in doing the work faster. It is in not having to undo it.
Where to start
Our Korea Market-Entry Diagnostic is deliberately scoped as a fixed-fee, two-week engagement covering trademark exposure, regulatory gates, partner structure, and a recommended entry sequence you can act on immediately, whether you then execute in-house or with us.
If the diagnostic tells you your Korean plan is sound, that is a good outcome. Most of the time it tells us where the money was about to go.